Unique features of infective endocarditis in childhood

Circulation

Volumn 105, Issue 17, 2002, Pages 2115-2127

  Ferrieri, Patricia ^a   Gewitz, Michael H ^a   Gerber, Michael A ^a   Newburger, Jane W ^a   Dajani, Adnan S ^a   Shulman, Stanford T ^a   Wilson, Walter ^a   Bolger, Ann F ^a   Bayer, Arnold ^a   Levison, Matthew E ^a   Pallasch, Thomas J ^a   Gage, Tommy W ^a   Taubert, Kathryn A ^a  

^a AMERICAN HEART ASSOCIATION   (United States)

Author keywords

AHA scientific statements; Endocarditis; Infection; Pediatrics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; FLUCONAZOLE; FLUCYTOSINE; GENTAMICIN; IMIDAZOLE DERIVATIVE; NAFCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; VANCOMYCIN;

ANTIMICROBIAL THERAPY; BACTERIAL ENDOCARDITIS; CHILD; CHILDHOOD DISEASE; CLASSIFICATION; CLINICAL FEATURE; HEART SURGERY; HUMAN; LABORATORY TEST; PATHOGENESIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; CARDIAC SURGICAL PROCEDURES; CHILD; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; INFANT; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 0037197749     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000013073.22415.90     Document Type: Review

References (76)

1. Infective endocarditis
2. Infective endocarditis in infants and children during the past 10 years: A decade of change
3. Endocarditis in children
4. Pediatric infective endocarditis in the modern era
5. Infective endocarditis: 35 years of experience at a children's hospital
6. Thirty-year incidence of infective endocarditis after surgery for congenital heart defect
7. Are the Duke criteria superior to Beth Israel criteria for diagnosis of infective endocarditis in children?
8. Infective endocarditis in children with congenital heart disease: Comparison of selected features in patients with surgical correction or palliation and those without
9. The changing spectrum of neonatal endocarditis
10. Endocarditis in high-risk neonates
11. Endocarditis following intracardiac placement of umbilical venous catheters in neonates
12. Neonatal Staphylococcus epidermidis right-sided endocarditis: Description of five catheterized infants
13. Experimental models of endocarditis
14. Central venous catheter-induced endocarditis: Human correlate of the animal experimental model of endocarditis
15. Experimental bacterial endocarditis. 1. Colonization of a sterile vegetation
16. Experimental bacterial endocarditis. II. Survival of bacteria in endocardial vegetations
17. The changing pattern of infective endocarditis in childhood
18. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect
19. Infective endocarditis in the adult with congenital heart disease
20. The pathogenesis of infective endocarditis
21. Immunization for prevention of infective endocarditis
22. Antimicrobial peptides from platelets
23. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings, Duke Endocarditis Service
24. Infective endocarditis in children: Clinical analyses and evaluation of two diagnostic criteria
25. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis
26. Actinobacillus actinomycetemcomitans in human periodontal disease: A cross-sectional microbiological investigation
27. Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis
28. A forty-year review of bacterial endocarditis in infancy and childhood
29. Diagnosis and management of infective endocarditis and its complications
30. Spectrum of echocardiographic findings in bacterial endocarditis
31. Two-dimensional echocardiogruphic assessment of infective endocarditis in children
32. Echocardiographic evaluation of endocarditis in children
33. Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions
34. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: Experience in 103 patients
35. Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis: Clinical and surgical implications
36. Penetration of the atrialventricular septum by spread of infection from aortic valve endocarditis: Early diagnosis by transesophageal echocardiography and implications for surgical management
37. Natural history of vegetations during successful medical treatment of endocarditis
38. Echocardiography in infective endocarditis: Reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach
39. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms
40. Response to therapy: Relapses and reinfections
41. Single-antibiotic therapy for streptococcal endocarditis
42. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks: Efficacy and outpatient treatment feasibility
43. Short-term therapy for streptococcal infective endocarditis: Combined intramuscular administration of penicillin and streptomycin
44. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci
45. Pneumococcal endocarditis is not just a disease of the past: An analysis of 16 cases diagnosed in Denmark in 1986-1997
46. Review of pneumococcal endocarditis in adults in the penicillin era
47. Streptococcus pneumoniae endocarditis in adults: A multicenter study in France in the era of penicillin resistance (1991-1998)
48. Enterococcal endocarditis
49. Aminoglycoside resistant enterococcal endocarditis
50. Staphylococcal endocarditis
51. Infection of prosthetic heart valves and vascular grafts
52. Staphylococcus aureus prosthetic valve endocarditis: Optimal management and risk factors for death
53. Prosthetic valve endocarditis: Analysis of risk factors for mortality
54. Prosthetic valve endocarditis in the ICU: Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decisions
55. Prosthetic valve endocarditis: Superiority of surgical valve replacement versus medical therapy only
56. Clinical features of Staphylococcus aureus endocarditis: A 10-year experience in Denmark
57. Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria: Report of 56 cases
58. Infective endocarditis
59. Cardiac valve replacement in congestive heart failure due to infective endocarditis
60. Treatment of infective endocarditis: A 10-year comparative analysis
61. Surgical treatment of infective endocarditis
62. Analysis of surgical versus medical therapy in active complicated native valve infective endocarditis
63. Predictive risk factors for periannular extension of native valve endocarditis: Clinical and echocardiographic analyses
64. Perivalvular extension of infection in patients with infectious endocarditis
65. Identification of abscess formation in native-valve infective endocarditis using transesophageal echocardiography: Implications for surgical treatment
66. Endocarditis-associated paravalvular abscesses: Do clinical parameters predict the absence of abscess?
67. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size
68. Infective endocarditis: An evolving discussion. A review of endocarditis at the Columbia-Presbyterian Medical Center. 1968-1973
69. Surgical therapy of infective endocarditis on natural valves
70. Surgical management of infective endocarditis in children
71. Operative intervention in active endocarditis in children: Report of a series of cases and review
72. Risk factors for infective endocarditis
73. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
74. Risks for and prevention of infective endocarditis
75. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
76. Subacute bacterial endocarditis: Considerations for the pediatric patients